The acute phase reactant orosomucoid-2 directly promotes rheumatoid inflammation
In conclusion, the acute phase protein ORM2 can directly increase the production of proinflammatory mediators and promote chronic arthritis in mice, suggesting that ORM2 could be a new therapeutic target for RA.PMID:38556552 | DOI:10.1038/s12276-024-01188-0
Source: Molecular Medicine - Category: Molecular Biology Authors: Ki-Myo Kim Kang-Gu Lee Saseong Lee Bong-Ki Hong Heejae Yun Yune-Jung Park Seung-Ah Yoo Wan-Uk Kim Source Type: research
More News: Arthritis | Liver | Molecular Biology | Radiography | Rheumatoid Arthritis | Rheumatology | Urology & Nephrology